Table of Contents
Zepbound vs. Wegovy: A Comparison
Zepbound and Wegovy are injectable medications, both GLP-1 receptor agonists, aiding weight loss by mimicking the effects of the hormone GLP-1, regulating blood sugar and appetite.
Characteristic | Zepbound | Wegovy |
---|---|---|
Active ingredient | Tirzepatide | Semaglutide |
Approval type | Obesity | Obesity with at least one weight-related condition (e.g., type 2 diabetes) |
Dosage | Weekly | Weekly or twice weekly |
Side effects | Gastrointestinal (nausea, vomiting, diarrhea, constipation) | Gastrointestinal (nausea, vomiting, diarrhea, constipation) |
Cost | $1,000-$2,000 per month | $1,300 per month |
Key Differences:
- Approval Type: Zepbound for obesity; Wegovy for obesity with a weight-related condition.
- Dosage: Zepbound weekly; Wegovy weekly or twice weekly.
- Cost: Zepbound’s expected range $1,000-$2,000; Wegovy priced around $1,300 per month.
Choosing the Right Drug: Consider factors such as approval type, dosage preference, and budget. Consult your doctor to tailor a treatment plan based on your individual needs, weighing risks and benefits.
Average weight loss for Zepbound and Wegovy in clinical trials
The table below displays the average weight loss achieved by patients in clinical trials of Zepbound and Wegovy:
Drug | Average Weight Loss (%) |
---|---|
Zepbound | 17.4% |
Wegovy | 15.3% |
Both Zepbound and Wegovy demonstrate substantial effectiveness in weight loss, with Zepbound showing a slightly greater average weight loss in clinical trials.
Limitations of Direct Comparisons
It’s crucial to recognize the challenges in directly comparing the efficacy of Zepbound and Wegovy due to differences in trial design. Notably, the Zepbound trials were longer, and the patient populations varied. Some additional limitations include:
- Patient Demographics: Zepbound trials included more patients with obesity than Wegovy trials.
- Dosing Schedule: Zepbound trials employed a slightly different dosing schedule compared to Wegovy trials.
- Geographical Variation: Zepbound trials were conducted in multiple countries, whereas Wegovy trials were primarily in the United States.
Despite these limitations, the available clinical evidence suggests that both Zepbound and Wegovy are highly effective for weight loss. While Zepbound may exhibit a slight edge in average weight loss, the overall efficacy of both drugs remains substantial. These medications offer valuable options for individuals with obesity, aiding in weight loss and overall health improvement.
Zepbound vs Wegovy Coupons and Discount
Zepbound Coupons and Discount
- Manufacturer savings card: Eli Lilly, the manufacturer of Zepbound, offers a savings card that can reduce the cost of the drug by up to 50%. This card is available to all patients, regardless of their insurance status.
- Patient assistance programs: Eli Lilly also offers patient assistance programs to help uninsured and underinsured patients afford Zepbound. These programs can provide financial assistance to help cover the cost of the drug and other associated expenses, such as copays and deductibles.
- Health insurance: Some health insurance plans cover Zepbound, but coverage and copays can vary depending on the plan. Be sure to check with your insurance company to see if Zepbound is covered and what your out-of-pocket costs would be.
Wegovy Coupons and Discount
Manufacturer savings card: Novo Nordisk, the manufacturer of Wegovy, offers a savings card that can reduce the cost of the drug by up to $750 per month. This card is available to all patients with commercial insurance.
- Patient assistance programs: Novo Nordisk also offers patient assistance programs to help uninsured and underinsured patients afford Wegovy. These programs can provide financial assistance to help cover the cost of the drug and other associated expenses, such as copays and deductibles.
- Health insurance: Most health insurance plans cover Wegovy, but coverage and copays can vary depending on the plan. Be sure to check with your insurance company to see if Wegovy is covered and what your out-of-pocket costs would be.
Table:
Drug | Savings program | Eligibility | Discount |
---|---|---|---|
Zepbound | Manufacturer savings card | All patients | Up to 50% |
Zepbound | Patient assistance programs | Uninsured and underinsured patients | Varies |
Zepbound | Health insurance | Varies | Varies |
Wegovy | Manufacturer savings card | Patients with commercial insurance | Up to $750 per month |
Wegovy | Patient assistance programs | Uninsured and underinsured patients | Varies |
Wegovy | Health insurance | Most plans | Varies |
It’s important to note that coupons and discounts cannot be combined. If you are eligible for multiple savings programs, you will need to choose one to use.